Isolated limb infusion as a model to test new agents to treat metastatic melanoma

Michael E. Lidsky, Paul J. Speicher, Betty Jiang, Masahito Tsutsui, Douglas Tyler

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The limb model of in-transit disease can expand our understanding of treating melanoma because of the ease of obtaining tissue biopsies for correlative studies and the availability of preclinical animal models that allow validation of novel therapeutic strategies. This review will focus on regional therapy for in-transit melanoma as a platform to investigate novel therapeutic approaches to improve regional disease control, and help us develop insights to more rationally design systemic therapy trials. J. Surg. Oncol. 2014 109:357-365.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalJournal of Surgical Oncology
Volume109
Issue number4
DOIs
StatePublished - Mar 2014
Externally publishedYes

Fingerprint

Melanoma
Extremities
Therapeutics
Animal Models
Biopsy

Keywords

  • in-transit
  • isolated limb infusion
  • melanoma

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Isolated limb infusion as a model to test new agents to treat metastatic melanoma. / Lidsky, Michael E.; Speicher, Paul J.; Jiang, Betty; Tsutsui, Masahito; Tyler, Douglas.

In: Journal of Surgical Oncology, Vol. 109, No. 4, 03.2014, p. 357-365.

Research output: Contribution to journalArticle

Lidsky, Michael E. ; Speicher, Paul J. ; Jiang, Betty ; Tsutsui, Masahito ; Tyler, Douglas. / Isolated limb infusion as a model to test new agents to treat metastatic melanoma. In: Journal of Surgical Oncology. 2014 ; Vol. 109, No. 4. pp. 357-365.
@article{1c2eff3772c84a7d92b4d557476301b1,
title = "Isolated limb infusion as a model to test new agents to treat metastatic melanoma",
abstract = "The limb model of in-transit disease can expand our understanding of treating melanoma because of the ease of obtaining tissue biopsies for correlative studies and the availability of preclinical animal models that allow validation of novel therapeutic strategies. This review will focus on regional therapy for in-transit melanoma as a platform to investigate novel therapeutic approaches to improve regional disease control, and help us develop insights to more rationally design systemic therapy trials. J. Surg. Oncol. 2014 109:357-365.",
keywords = "in-transit, isolated limb infusion, melanoma",
author = "Lidsky, {Michael E.} and Speicher, {Paul J.} and Betty Jiang and Masahito Tsutsui and Douglas Tyler",
year = "2014",
month = "3",
doi = "10.1002/jso.23502",
language = "English (US)",
volume = "109",
pages = "357--365",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Isolated limb infusion as a model to test new agents to treat metastatic melanoma

AU - Lidsky, Michael E.

AU - Speicher, Paul J.

AU - Jiang, Betty

AU - Tsutsui, Masahito

AU - Tyler, Douglas

PY - 2014/3

Y1 - 2014/3

N2 - The limb model of in-transit disease can expand our understanding of treating melanoma because of the ease of obtaining tissue biopsies for correlative studies and the availability of preclinical animal models that allow validation of novel therapeutic strategies. This review will focus on regional therapy for in-transit melanoma as a platform to investigate novel therapeutic approaches to improve regional disease control, and help us develop insights to more rationally design systemic therapy trials. J. Surg. Oncol. 2014 109:357-365.

AB - The limb model of in-transit disease can expand our understanding of treating melanoma because of the ease of obtaining tissue biopsies for correlative studies and the availability of preclinical animal models that allow validation of novel therapeutic strategies. This review will focus on regional therapy for in-transit melanoma as a platform to investigate novel therapeutic approaches to improve regional disease control, and help us develop insights to more rationally design systemic therapy trials. J. Surg. Oncol. 2014 109:357-365.

KW - in-transit

KW - isolated limb infusion

KW - melanoma

UR - http://www.scopus.com/inward/record.url?scp=84893946619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893946619&partnerID=8YFLogxK

U2 - 10.1002/jso.23502

DO - 10.1002/jso.23502

M3 - Article

C2 - 24522940

AN - SCOPUS:84893946619

VL - 109

SP - 357

EP - 365

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -